{"name": "NUCRYST Pharmaceuticals",
 "permalink": "nucryst-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/nucryst-pharmaceuticals",
 "homepage_url": "http://www.nucryst.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 21 11:53:19 UTC 2010",
 "updated_at": "Thu Jan 21 12:01:51 UTC 2010",
 "overview": "\u003Cp\u003ENUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith \u0026amp; Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0007/4316/74316v1-max-150x150.jpg"],
     [[250,
       76],
      "assets/images/resized/0007/4316/74316v1-max-250x250.jpg"],
     [[269,
       82],
      "assets/images/resized/0007/4316/74316v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.westaim.com/News/PressReleases/PressReleaseDetails/2009/WestaimAnnouncesAmalgamationAgreementwithNUCRYSTPharmaceuticals1121225/default.aspx",
   "source_description": "Westaim Announces Amalgamation Agreement with NUCRYST Pharmaceuticals",
   "acquired_year": 2009,
   "acquired_month": 11,
   "acquired_day": 10,
   "acquiring_company":
    {"name": "Westaim",
     "permalink": "westaim",
     "image":
      {"available_sizes":
        [[[150,
           33],
          "assets/images/resized/0007/4318/74318v1-max-150x150.jpg"],
         [[167,
           37],
          "assets/images/resized/0007/4318/74318v1-max-250x250.jpg"],
         [[167,
           37],
          "assets/images/resized/0007/4318/74318v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}